-The Telegraph Bhubaneswar (Odisha): The Centre-sponsored Jan Aushadhi scheme is suffering from shortage of medicines and reluctance of doctors to prescribe drugs by their generic names. The scheme, which is being run by the Odisha branch of the Indian Red Cross Society in 22 districts of the state, was launched to sell quality generic medicines at subsidised prices. Though the city has two Jan Aushadhi stores, chances are that you will have to...
More »SEARCH RESULT
Total Matching Records found : 137
Govt to sell 439 key drugs at low prices -Sushmi Dey
-The Times of India NEW DELHI: The government is set to expand the coverage of its Jan Aushadhi scheme. It will offer 439 life-saving medicines, including cancer and cardiovascular drugs, as well as 250 medical devices like stents and implants at 40-50% discounted prices. The department of pharmaceuticals plans to open 300 Jan Aushadhi stores across the country by March and another 3,000 by 2017. Presently, only 45 medicines are available in...
More »Nothing free or basic about it -Prabir Purkayastha
-The Hindu We need to provide full Internet at prices people can afford, not privilege private platforms. This is where India’s regulatory system has to step in The airwaves, the newspapers and even the online space are now saturated with a Rs. 100 crore campaign proclaiming that Internet connectivity for the Indian poor is a gift from Facebook which a few churlish net neutrality fundamentalists are opposing. In its campaign, Facebook is...
More »Govt caps prices of another 106 drugs -Sushmi Dey
-The Times of India NEW DELHI: For bringing down prices of medicines for critical diseases like cancer, HIV and diabetes, the government has revised the national list of essential medicines (NLEM) to add 106 more drugs while 70 other drugs, which are not prescribed frequently or where better alternatives are now available in the market, have been taken off the list. This means, the total number of essential medicines, prices of which...
More »Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey
-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...
More »
